Endothelial Lipase as a New Diagnostic Marker in Patients with Nonalcoholic Fatty Liver Disease and Metabolic Syndrome

Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/24887

Full metadata record

DC Field	Value	Language
dc.contributor.author	Bashkirova, Anna	-
dc.date.accessioned	2019-11-26T07:52:22Z	-
dc.date.available	2019-11-26T07:52:22Z	-
dc.date.issued	2019	-
dc.identifier.citation	Bashkirova A. Endothelial Lipase as a New Diagnostic Marker in Patients with Nonalcoholic Fatty Liver Disease and Metabolic Syndrome / A. Bashkirova // International Conference on Fatty Liver (ICFL), Berlin, Germany, June 27–29 2019 : Abstract book. – Berlin, 2019. – P. 24–25.	ru_RU
dc.identifier.uri	http://repo.knmu.edu.ua/handle/123456789/24887	-
dc.description.abstract	The concentration of EL is lowest in patients of the control group and increases progressively with steatosis and metabolic syndrome compared with those suffering from hypertension without steatosis and metabolic syndrome. In ad- dition, an increase in EL is associated with the presence of met- abolic disorders, which, in aggregate, makes it possible to at- tribute it to independent markers of the atherosclerotic process and cardiovascular risk.	ru_RU
dc.language.iso	en	ru_RU
dc.subject	NAFLD	ru_RU
dc.subject	metabolic syndrome	ru_RU
dc.subject	endothelial lipase	ru_RU
dc.title	Endothelial Lipase as a New Diagnostic Marker in Patients with Nonalcoholic Fatty Liver Disease and Metabolic Syndrome	ru_RU
dc.type	Thesis	ru_RU
Appears in Collections:	Наукові праці. Кафедра внутрішньої медицини № 1

Files in This Item:

File	Description	Size	Format
БЕРЛИН.pdf		183,31 kB	Adobe PDF	View/Open

Kharkiv National Medical University Repository